Fatty acids and atopic disease
P. C. Calder,
E. A. Miles,
P. C. Calder
Institute of Human Nutrition, University of Southampton, Southampton, UK
Search for more papers by this authorE. A. Miles
Institute of Human Nutrition, University of Southampton, Southampton, UK
Search for more papers by this authorP. C. Calder,
E. A. Miles,
P. C. Calder
Institute of Human Nutrition, University of Southampton, Southampton, UK
Search for more papers by this authorE. A. Miles
Institute of Human Nutrition, University of Southampton, Southampton, UK
Search for more papers by this authorP.C. Calder, Institute of Human Nutrition, University of Southampton, Bassett Crescent East, Southampton, SO16 7PX, U.K.
References
- 1 Dahlen SE, Hedquist P, Hammarstrom S, et al. Leuko-trienes are potent constrictors of human bronchi. Nature 1980; 11: 484 486.
- 2 Henderson WR. Role of leukotrienes in asthma. Ann Allergy 1994; 72: 272 278.
- 3 Weller PF, Lee CW, Foster DW, et al. Generation and metabolism of 5-lipoxygenase pathway leukotrienes by human eosinophils: predominant production of LTC4. Proc Natl Acad Sci USA 1983; 80: 7626 7630.
- 4 Peters SP, MacGlashan DW, Schulman ES, et al. Arachi-donic acid metabolism in purified human lung mast cells. J Immunol 1984; 132: 1972 1979.
- 5 Chavis C, Godard P, Michel FB, et al. Sulfidopeptide leukotrienes contribute to human alveolar macrophage activation in asthma. Prost Leuk Ess Fatty Acids 1991; 42: 95 100.
- 6 Lewis RA, Austen KF, Soberman RJ. Leukotrienes and other products of the 5-lipoxygenase pathway: biochemistry and relation to pathobiology in human diseases. N Engl J Med 1990; 323: 645 655.
- 7 Snijdewint FGM, Kalinski P, Wieringa EA, et al. Prostaglandin E2 differentially modulates cytokine secretion profiles in human T-helper lymphocytes. J Immunol 1993; 150: 5321 5329.
- 8 Gold KN, Weyand CM, Goronzy JJ. Modulation of helper T-cell function by prostaglandins. Arth Rheum 1994; 37: 925 933.
- 9 Roper RL & Phipps RP. Prostaglandin E2 and cAMP inhibit B-lymphocyte activation and simultaneously promote IgE and IgG1 synthesis. J Immunol 1992; 149: 2984 2991.
- 10 Roper RL, Brown DM, Phipps RP. Prostaglandin E2 promotes B-lymphocyte Ig isotype switching to IgE. J Immunol 1995; 154: 162 170.
- 11 British Nutrition Foundation. Unsaturated Fatty Acids: Nutrition and Physiological Significance, London: Chapman and Hall, 1992.
- 12 Burr ML, Butland BK, King S, et al. Changes in asthma prevalence: two surveys 15 years apart. Arch Dis Child 1989; 64: 1452 1456.
- 13 Burney PGJ, Chinn S, Rona RJ. Has the prevalence of asthma increased in children? Evidence from the national survey of health and growth 1973–1986. Br Med J 1990; 300: 1306 1310.
- 14 Yuninger JW, Reed CE, O'connell EJ, et al. A community-based study of epidemiology of asthma. Am Rev Resp Dis 1992; 146: 888 894.
- 15 Von Mutius E, Fritzsch C, Weiland SK, et al. Prevalence of asthma and allergic disorders among children in united Germany: a descriptive comparison. Br Med J 1992; 305: 1395 1399.
- 16 Von Mutius E, Martinez FD, Fritzsch C, et al. Prevalence of asthma and atopy in two areas of West and East Germany. Am J Resp Crit Care Med 1994; 149: 358 364.
- 17 Nowack D, Heinrich J, Beck E, et al. Differences in respiratory symptoms between two cities in Western and Eastern Germany: the first report in adults. Am Rev Resp Dis 1993; 147: A378.
- 18 Klein K, Dathe R, Gollnitz S, et al. Allergies: a com-parison between two vocational schools in East and West Germany. Acta Psychiatr Scand 1992; 47 (suppl 12): 259.
- 19 Winkler G, Holtz H, Doring A. Comparison of food intakes of selected populations in former East and West Germany: results from the MONICA projects, Erfurt and Augsburg. Ann Nutr Metab 1992; 36: 219 234.
- 20 Akerblom HK, Viikari J, Uhari M, et al. Atherosclerosis precursors in Finnish children. I. General description of the cross-sectional study of 1980, and an account of the children's and families' state of health. Acta Paediatr Scand 1985; Suppl 318: 49 63.
- 21 Poysa L, Korppi M, Pietikainen, et al. Asthma, allergic rhinitis and atopic eczema in Finnish children. Acta Psychiatr Scand 1991; 46: 161 165.
- 22 Moilanen T, Nikkari T, Viikari J, et al. Atherosclerosis precursors in Finnish children and adolescents. V. Fatty acid composition of serum cholesteryl esters: regional differences in Finland. Acta Paediatr Scand 1985; Suppl 318: 111 117.
- 23 Black PN & Sharpe S. Dietary fat and asthma: is there a connection? Eur Resp J 1997; 10: 6 12.
- 24 Hodge L, Peat JK, Salome C. Increased consumption of polyunsaturated oils may be a cause of increased prev-alence of childhood asthma. Aust NZ J Med 1994; 24: 727.
- 25 Manku MS, Horrobin DF, Morse NL, et al. Essential fatty acids in the plasma phospholipids of patients with atopic eczema. Br J Dermatol 1984; 110: 643 648.
- 26 Manku MS, Horrobin DF, Morse N, et al. Reduced levels of prostaglandin precursors in the blood of atopic patients: defective delta-6-desaturase function as a biochemical basis for atopy. Prost Leuk Med 1982; 9: 615 628.
- 27 Strannegard IL, Svennerholm L, Strannegard O. Essential fatty acids in serum lecithin of children with atopic dermatitis and in umbilical cord serum of infants with high or low IgE levels. Int Arch Allery Appl Immunol 1987; 82: 422 423.
- 28 Wright S. Atopic dermatitis and essential fatty acids: a biochemical basis for atopy? Acta Derm Venereol 1985; 114 (suppl): 143 145.
- 29 Galli E, Picardo M, De Luca C, et al. Essential fatty acids in cord blood lymphocytes of infants “at risk” of atopy. Pediatr Res 1989; 26: 519.
- 30 Melnik BC & Plewig G. Is the origin of atopy linked to deficient conversion of omega-6-fatty acids to prostaglandin E1? J Am Acad Dermatol 1989; 21: 557 563.
- 31 Wright S & Bolton C. Breast milk fatty acids in mothers of children with atopic eczema. Br J Nutr 1989; 62: 693 697.
- 32 Wright S & Sanders TA. Adipose tissue essential fatty acid composition in patients with atopic eczema. Eur J Clin Nutr 1991; 45: 501 505.
- 33 Oliwiecki S, Burton JL, Elles K, et al. Levels of essential and other fatty acids in plasma and red cell phospholipids from normal controls and patients with atopic eczema. Acta Derm Venereol 1991; 71: 224 228.
- 34 Biagi PL, Hrelia S, Celadon M, et al. Erythrocyte membrane fatty acid composition in children with atopic dermatitis compared to age-matched controls. Acta Paediatr 1993; 82: 789 790.
- 35 Galli E, Picardo M, Chini L, et al. Analysis of polyunsat-urated fatty acids in new-born sera: a screening tool for atopic disease? Br J Dermatol 1994; 130: 752 756.
- 36 Ioppi M, Businco L, Arcese G, et al. Cord blood mono-nuclear leukocytes of neonates at risk of atopy have a deficiency of arachidonic acid. J Invest Allergol Clin Immunol 1994; 4: 272 276.
- 37 Yu G, Duchen K, Bjorksten B. Fatty acid composition in colostrum and mature milk from non-atopic and atopic mothers during the first 6 months of lactation. Acta Paediatr 1998; 87: 729 736.
- 38 Leichsenring M, Kochsiek U, Paul K. (n-6) Fatty acids in plasma lipids of children with atopic bronchial asthma. Pediatr Allergy Immunol 1995; 6: 209 212.
- 39 Melnik BC & Plewig G. Atopy: a prostaglandin E precursor- and receptor-dependent defect in T-cell maturation and function? Br J Dermatol 1990; 123: 126 128.
- 40 Yu G & Bjorksten B. Polyunsaturated fatty acids in school children in relation to allergy and serum IgE levels. Pediatr Allergy Immunol 1998; 9: 133 138.
- 41 Yu G & Bjorksten B. Serum levels of phospholipid fatty acids in mothers and their babies in relation to allergic disease. Eur J Pediatr 1998; 157: 298 303.DOI: 10.1007/s004310050815
- 42 Melnik BC, Plewig G, Tschung T. Disturbances of essential fatty acid-mediated and prostaglandin E-mediated immunoregulation in atopy. Prost Leuk Ess Fatty Acids 1991; 42: 125 130.
- 43 Yu G, Kjellman NI, Bjorksten B. Phospholipid fatty acids in cord blood: family history and development of allergy. Acta Paediatr 1996; 85: 679 683.
- 44 Kromann N & Green A. Epidemiological studies in the Upernavik District, Greenland. Acta Med Scand 1980; 208: 401 406.
- 45 Schwartz J & Weiss ST. The relationship of dietary fish intake to level of pulmonary–function in the First National Health and Nutrition Survey. Eur Resp J 1994; 7: 1821 1824.
- 46 Schwartz J & Weiss ST. Dietary factors and their relation to respiratory symptoms: the Second National Health and Nutrition Survey. Am J Epidemiol 1990; 132: 67 76.
- 47 Hodge L, Salome CE, Peat JK, et al. Consumption of oily fish and childhood asthma risk. Med J Aust 1996; 164: 137 140.
- 48 Hammerstrom S. Conversion of dihomogammalinolenic acid to an isomer of leukotriene C3 oxygenated at C-8. J Biol Chem 1981; 256: 7712 7714.
- 49 Ziboh VA & Chapkin RS. Biologic significance of polyunsaturated fatty acids in the skin. Arch Dermatol 1987; 123: 1686 1690.
- 50 Miller CC, McCreedy CA, Jones AD, et al. Oxidative metabolism of dihomogammalinolenic acid by guinea pig epidermis: evidence of generation of anti–inflammatory products. Prostaglandins 1988; 6: 917 938.
- 51 Kelly JP & Parker CW. Effects of arachidonic and other unsaturated fatty acids on mitogenesis in human lympho cytes. J Immunol 1979; 122: 1556 1562.
- 52 Soyland E, Nenseter MS, Braathen L, et al. Very long chain n-3 and n-6 polyunsaturated fatty acids inhibit proliferation of human T lymphocytes in vitro. Eur J Clin Invest 1993; 23: 112 121.
- 53 Santoli D, Phillips PD, Colt TL, et al. Suppression of interleukin-2-dependent human T cell growth in vitro by prostaglandin E (PGE) and their precursor fatty acids. J Clin Invest 1990; 85: 424 432.
- 54 Borofsky MA, Zurier RB, Rosenbaum H, et al. Effects of polyunsaturated fatty acids on interleukin-2 dependent T cell growth. Immunol Res 1992; 11: 154 164.
- 55 De Marco DM, Santoli D, Zurier RB. Effects of fatty acids on proliferation and activation of human synovial compartment lymphocytes. J Leuk Biol 1994; 56: 612 615.
- 56 Santoli D & Zurier RB. Prostaglandin E (PGE) precursor fatty acids inhibit human IL-2 production by a PGE-independent mechanism. J Immunol 1989; 143: 1303 1309.
- 57 Rossetti RG, De Luca P, Seiler CM, et al. Modification of human lymphocyte and monocyte function by gammalinolenic acid, an unsaturated fatty acid: Studies in vitro and in vivo. Arth Rheum 1997; 40: S177.
- 58
Horrobin DF.
n-6 Fatty acids and atopic eczema. In: JM Kremer, ed.
Medicinal Fatty Acids in Inflammation. Basel: Birkhauser Verlag, 1998: 55 64.
10.1007/978-3-0348-8825-7_4 Google Scholar
- 59
Lovell CR,
Burton JL,
Horrobin DF.
Treatment of atopic eczema with evening primrose oil.
Lancet
1981; i: 278.
10.1016/S0140-6736(81)92119-X Google Scholar
- 60
Wright S &
Burton SL.
Oral evening primrose oil im-proves atopic eczema.
Lancet
1982; ii: 1120 1122.
10.1016/S0140-6736(82)92784-2 Google Scholar
- 61 Schalin-Karrila M, Mattila L, Jansen CT, et al. Even-ing primrose oil in the treatment of atopic eczema: effect on clinical status, plasma phospholipid fatty acids and circulating prostaglandins. Br J Dermatol 1987; 117: 11 19.
- 62 Sugai T. Clinical evaluation of oral evening primrose oil in atopic patients. Skin Res 1987; 29: 330 338.
- 63 Bordoni A, Biagi PL, Masi M, et al. Evening primrose oil (Efamol) in the treatment of children with atopic eczema. drugs Exp Clin Res 1988; 14: 291 297.
- 64 Biagi PL, Bordoni A, Masi M, et al. A long-term study on the use of evening primrose oil (Efamol) in atopic children. Drugs Exp Clin Res 1988; 14: 285 290.
- 65 Biagi PL, Bordoni A, Hrelia S, et al. The effect of gamma-linolenic acid on clinical status, red cell fatty acid com-position and membrane microviscosity in infants with atopic dermatitis. Drugs Exp Clin Res 1994; 20: 77 84.
- 66 Fiocchi A, Sala M, Signoroni P, et al. The efficacy and safety of gamma-linolenic acid in the treatment of infantile atopic dermatitis. J Int Med Res 1994; 22: 24 32.
- 67 Hederos CA & Berg A. Epogam evening primrose oil treat-ment in atopic dermatitis and asthma. Arch Dis Child 1996; 75: 494 497.
- 68 Courage B, Nissen HP, Wehrmann W, et al. Influence of polyunsaturated fatty acids on the plasma catecholamines of patients with atopic eczema. Z Hautkr 1991; 66: 509 510.
- 69 Morse PF, Horrobin DF, Manku MS, et al. Meta-analysis of placebo-controlled studies of the efficacy of Epogam in the treatment of atopic eczema. Relationship between plasma essential fatty acid changes and clinical response. Br J Dermatol 1989; 121: 75 90.
- 70 Calder PC. Sir David Cuthbertson Medal Lecture: Immunomodulatory and anti–inflammatory effects of omega-3 polyunsaturated fatty acids. Proc Nutr Soc 1996; 55: 737 774.
- 71
Calder PC.
n-3 Fatty acids and mononuclear phagocyte function. In: JM Kremer, ed.
Medicinal Fatty Acids. Basel: Birkhauser, 1998: 1 27.
10.1007/978-3-0348-8825-7_1 Google Scholar
- 72 Arm PJ, Horton CE, Mencia-Huerta JM, et al. Effect of dietary supplementation with fish oil lipids on mild asthma. Thorax 1988; 43: 84 92.
- 73 Chapkin RS, Hubbard NE, Erickson KL. 5-Series peptido-leukotriene synthesis in mouse peritoneal macrophages: modulation by dietary n-3 fatty acids. Biochem Biophys Res Commun 1990; 171: 764 769.
- 74 Chapkin RS, Akoh CC, Lewis RF. Dietary fatty acid modulation of in vivo peritoneal macrophage leukotriene production and phagocytosis. J Nutr Biochem 1991; 92: 599 604.
- 75 Broughton KS, Whelan J, Hardardottir D, et al. Effect of increasing the dietary (n-3) to (n-6) polyunsaturated fatty acid ratio on murine liver and peritoneal cell fatty acids and eicosanoid formation. J Nutr 1991; 121: 155 164.
- 76 Grimminger F, Fuhrer D, Papavassilis C, et al. Influence of intravenous n-3 lipid supplementation on fatty acid profiles and lipid mediator generation in a patient with severe ulcerative colitis. Eur J Clin Invest 1993; 23: 706 713.
- 77 Von Schacky C, Kiefl R, Jendraschak K, et al. n-3 Fatty acids and cysteinyl–leukotriene formation in humans in vitro, ex vivo and in vivo. J Lab Clin Med 1993; 121: 302 309.
- 78 Wachtler P, Konig W, Senkal M, et al. Influence of a total parenteral nutrition enriched with omega-3 fatty acids on leukotriene synthesis of peripheral leukocytes and systemic cytokine levels in patients with major surgery. J Trauma 1997; 42: 191 198.
- 79 Broughton KS, Johnson CS, Pace BK, et al. Reduced asthma symptoms with n-3 fatty acid ingestion are related to 5-series leukotriene production. Am J Clin Nutr 1997; 65: 1011 1017.
- 80 Lee TH, Hoover RL, Williams JD, et al. Effects of dietary enrichment with EPA and DHA on in vitro neutrophil and monocyte leukotriene generation and neutrophil function. N Engl J Med 1985; 312: 1217 1224.
- 81 Endres S, Ghorbani R, Kelley VE, et al. The effect of dietary supplementation with n-3 polyunsaturated fatty acids on the synthesis of interleukin-1 and tumor necrosis factor by mononuclear cells. N Engl J Med 1989; 320: 265 271.
- 82 Schmidt EB, Varming K, Pederson JO, et al. Long term supplementation with n-3 fatty acids. II. Effect on neutro-phil and monocyte chemotaxis. Scand J Clin Lab Invest 1992; 52: 229 236.
- 83 Kikuchi S, Sakamoto T, Ishikawa C, et al. Modulation of eosinophil chemotactic activities to leukotriene B-4 by n-3 polyunsaturated fatty acids. Prost Leuk Ess Fatty Acids 1998; 58: 243 248.
- 84 Sperling RI. Effects of dietary fish oil on leukocyte leukotriene and PAF generation and on neutrophil chemotaxis. World Rev Nutr Dietet 1991; 66: 391 400.
- 85 Meydani SN, Endres S, Woods MM, et al. Oral (n-3) fatty acid supplementation suppresses cytokine production and lymphocyte proliferation: comparison between young and older women. J Nutr 1991; 121: 547 555.
- 86 Meydani SN, Lichtenstein AH, Cornwall S, et al. Immunologic effects of national cholesterol education panel step-2 diets with and without fish-derived n-3 fatty acid enrichment. J Clin Invest 1993; 92: 105 113.
- 87 Caughey GE, Mantzioris E, Gibson RA, et al. The effect on human tumor necrosis factor α and interleukin 1β production of diets enriched in n-3 fatty acids from vegetable oil or fish oil. Am J Clin Nutr 1996; 63: 116 122.
- 88 Hughes DA, Pinder AC, Piper Z, et al. Fish oil supple-mentation inhibits the expression of major histocompatibility complex class II molecules and adhesion molecules on human monocytes. Am J Clin Nutr 1996; 63: 267 72.
- 89 Sanderson P & Calder PC. Dietary fish oil diminishes lymphocyte adhesion to macrophage and endothelial cell monolayers. Immunology 1998; 94: 79 87.
- 90 Fox T. Atlas of Skin Diseases. London: Churchill, 1877: 69.
- 91 Bjorneboe A, Soyland E, Bjorneboe G-EA, et al. Effect of dietary supplementation of eicosapentaenoic acid in the treatment of atopic dermatitis. Br J Dermatol 1987; 117: 463 469.
- 92 Arm JP, Horton CE, Spur BW, et al. The effects of dietary supplementation with fish oil lipids on the airways res-ponse to inhaled allergen in bronchial asthma. Am Rev Respir Dis 1989; 139: 1395 1400.
- 93 Hodge L, Salome CM, Hughes JM, et al. Effect of dietary intake of omega-3 and omega-6 fatty acids on severity of asthma in children. Eur Resp J 1998; 11: 361 365.
- 94 Thien FCK, Menciahuerta JM, Lee TK. Dietary fish oil effects on seasonal hay fever and asthma in pollen-sensitive subjects. Am Rev Resp Dis 1993; 147: 1138 1143.
- 95 Dry J & Vincent D. Effect of fish oil diet on asthma – Results of a 1-year double-blind study. Int Arch Allergy Appl Immunol 1991; 95: 156 157.
- 96 Masuev KA. Effects of polyunsaturated fatty acids on biochemical indices in patients with bronchial asthma. Terap Ark 1997; 69: 33 35.
- 97 Masuev KA. The effect of omega-3 polyunsaturated fatty acids on late phase of allergic reaction in patients with bronchial asthma. Terap Ark 1997; 69: 31 33.
- 98 Villani F, Comazzi R, De Maria P, et al. Effect of dietary supplementation with polyunsaturated fatty acids on bronchial hyperreactivity in subjects with seasonal asthma. Respiration 1998; 65: 265 269.
Citing Literature
